Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9609 posts found.

heptares_logo

Heptares announces positive early-stage dementia trial results

February 10, 2016 Research and Development Alzheimer's, Alzheimers, Heptares, dementia, schizophrenia

Heptares has announced positive findings from its Phase 1b clinical study with its investigational drug HTL9936 as a treatment for …
News

FDA advisory committee recommends approval of Remicade biosimilar

February 10, 2016 Research and Development, Sales and Marketing FDA, Pfizer, Remicade, biosimilar, celltrion

An FDA advisory panel yesterday voted overwhelmingly in favour of approving CT-P13- Celltrion’s biosimilar version of Johnson&Johnson’s blockbuster arthritis drug …
News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

New breast cancer initiative brings together pharma and Europe’s top researchers

February 9, 2016 Medical Communications, Research and Development Pfizer, breast cancer

The UK charity Breast Cancer Now (BCN) has announced a new initiative seeking to bring together Europe’s top researchers and …
News
fda

FDA set to approve Remicade biosimilar

February 9, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Remicade, biosimilars, remsima

An FDA committee has had some positive words for Celltrion’s biosimilar candidate to Janssen/MSD’s Remicade (infliximab), concluding that the copycat biologic …
News
nice

NICE rejects cholesterol drug Praluent in draft guidance

February 8, 2016 Research and Development, Sales and Marketing NICE, Regeneron, Sanofi, cholesterol

NICE has published draft guidance not recommending Sanofi/Regeneron’s Praluent (alirocumab) as an option for people with high cholesterol (primary hypercholesterolaemia …
News
shire_image_4

FDA to decide on Shire blockbuster hopeful

February 8, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Shire, dry eye disease, lifitegrast

The FDA has accepted Shire’s new drug application (NDA) for its dry eye disease drug lifitegrast, putting the treatment on …
News
opdivo

UK lung cancer patients get early access to breakthrough BMS drug

February 5, 2016 Research and Development, Sales and Marketing Bristol-Myers Squibb, MHRA, NICE, eams, opdivo

UK lung cancer patients are to get access to Bristol Myers-Squibb’s Opdivo (nivolumab) through the Early Access to Medicines Scheme …
News
la76169logo

Human Longevity makes three oncology appointments

February 4, 2016 Research and Development human longevity

Human Longevity, the genomics-based, technology company, has appointed ‘several key people’ for its oncology genomics program.Dr Kenneth Bloom will join …
Appointment
World Cancer Day 2016

Cancer – dealing with the greatest health challenge of our time

February 4, 2016 Manufacturing and Production, Research and Development Cancer, IFPMA, R&D, World Cancer Day, collaboration, partnership

Cancer is one of the greatest health challenges of our time, and a leading cause of death in every corner …
Feature
Spending graph

Emerging markets top global R&D spending league

February 4, 2016 Research and Development GDP, OECD, R&D spending, investment

Data from the Organisation for Economic Co-operation and Development (OECD) shows Korea and Israel are investing much more in research …
News
ICR Sutton

London launches new cancer drug development hub

February 3, 2016 Research and Development

Research charities, hospitals, and London boroughs have combined to launch a new global hub for cancer research and treatment in …
News
Adaptimmune

GSK and Adaptimmune expand R&D collaboration

February 3, 2016 Research and Development Adaptimmune, GSK, T-cell therapy, immunotherapy, liposarcoma, rare cancer, sarcoma

Adaptimmune Therapeutics and GlaxoSmithKline have expanded the terms of their strategic collaboration agreement, to run clinical trials of Adaptimmune’s potential …
News
Daiichi Sankyo researchers

Daiichi Sankyo to expand access to clinical trial data

February 3, 2016 Research and Development Daiichi Sankyo, R&D, clinical trials, open access, open data, transparency

Daiichi Sankyo has announced today that it will share clinical trial data to qualified researchers through an online web request …
News
Brandicourt

Sanofi plans R&D jobs cuts in France

February 3, 2016 Manufacturing and Production, Research and Development Sanofi, Teva, cuts, job losses, olivier brandicourt, redundancies

Sanofi chief executive Olivier Brandicourt is reported to be planning hundreds of job cuts across the firm’s base in France, …
News

Pfizer revenues down, but above expectations

February 3, 2016 Research and Development, Sales and Marketing Ian Read, Pfizer, financial results, income, profits, revenue, sales

Pfizer’s revenues took a hit from generic competition on former blockbusters, but the world’s new largest drugmaker still managed to …
News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026